In vivo synergism of roxithromycin (RU 965) and interferon against Toxoplasma gondii.
We investigated the activity of roxithromycin (RU 965) and gamma interferon alone and in combination in a murine model of toxoplasmic encephalitis. Roxithromycin at a dosage of 35 or 50 mg per mouse per day decreased mortality. Gamma interferon alone significantly prolonged time to death. When combi...
Na minha lista:
| 發表在: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
American Society for Microbiology (ASM)
1987
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC174724/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3105452/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.31.2.346 |
| 標簽: |
沒有標簽, 成為第一個標記此記錄!
|